GlassScriptPhysician profile
Brian J Blount
NPI 1710094842
$3,391.61
in general payments reported to CMS, 2019-2025
17 companies · $659 in 2025
The $659 reported for 2025 was more than what 84% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $325 · 2020: $149 · 2021: $841 · 2022: $222 · 2023: $529 · 2024: $667 · 2025: $659.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,855.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,855.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,068.72 | 2019-2024 | Total30, Precision 1, Dailies |
| Bausch & Lomb Americas INC. | $706.76 | 2022-2025 | Infuse, Infuse Multifocal, Miebo |
| Johnson & Johnson Vision Care, INC. | $391.17 | 2020-2025 | Acuvue |
| Oyster Point Pharma, INC. | $294.36 | 2023-2025 | Tyrvaya, Ryzumvi, Ryzumvi |
| Coopervision INC. | $242.99 | 2019-2025 | Clariti Contact Lens |
| Tarsus Pharmaceuticals, INC. | $141.48 | 2024-2025 | Xdemvy |
| Rxsight INC | $125.38 | 2023 | Rxsight Injector Cartridge, Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd) |
| Optos, INC. | $110.60 | 2021 | |
| Dompe US, INC. | $67.29 | 2024-2025 | Oxervate |
| Johnson & Johnson Surgical Vision, INC. | $61.06 | 2019 | |
| Harrow Eye, LLC | $38.52 | 2024-2025 | Vevye |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $36.75 | 2019-2020 | |
| Glaukos Corporation | $25.47 | 2022 | |
| Abbvie INC. | $24.68 | 2022 | |
| Allergan, INC. | $23.54 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Shire North American Group INC | $13.44 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Blount listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.